CTC Alternative Strategies, Ltd.
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 1569550
CHICAGO, IL
Position in ZNTL
as of Mar 31, 2026
· filed May 21, 2026
Position Value
$29,250
New position
Shares Held
12,500
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026CTC Alternative Strategies, Ltd. holds $923,493 across 14 Biotechnology names. ZNTL ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
925 | $298,025 | |
| 2 | IMUX |
Immunic, Inc.
|
24,390 | $270,729 | |
| 3 | NAUT |
Nautilus Biotechnology, Inc.
|
12,397 | $48,100 | |
| 4 | MNKD |
Mannkind Corp
|
16,400 | $40,180 | |
| 5 | OCGN |
Ocugen, Inc.
|
18,633 | $33,725 | |
| 6 | PALI |
Palisade Bio, Inc.
|
17,441 | $30,521 | |
| 7 | ZNTL |
Zentalis Pharmaceuticals, Inc.
This page
|
12,500 | $29,250 | |
| 8 | CRBU |
Caribou Biosciences, Inc.
|
15,076 | $28,644 |
All Filings in ZNTL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,250 | 12,500 | Shares | Sole | 2026-05-21 | |
| No filing history on record for this holder in this stock. | ||||||